Cardiovascular
1 drug is in development for Vascular Diseases.
- Companies
- 1
- Clinical trials
- 8
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Vascular Diseases pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Ralinepag | UNITED THERAPEUTICS Corp (UTHR) |
About this indication
Vascular Diseases context
Cardiovascular·MeSH: Vascular Diseases (D014652)
Also known as: Disease, Vascular
Prevalence
8121.9 / 100K
Incidence
682.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Vascular Diseases?
BioSniper tracks 1 drug in development for Vascular Diseases across 1 company.
How many clinical trials target Vascular Diseases?
There are 8 clinical trials targeting Vascular Diseases tracked by BioSniper.
What is the prevalence of Vascular Diseases?
The estimated prevalence of Vascular Diseases is approximately 8121.9 per 100,000 population.